🟢 Krystal Biotech is trading 4.24% up today; catalyst remains unclear

Krystal Biotech is trading 4.24% up at $348.01, with no clear company-specific catalyst identified.

• No announcement, earnings release, regulatory decision, or analyst action dated September 22, 2026 was identified.
• Its latest notable event was a September 10 Cantor Fitzgerald presentation covering pipeline progress and slowing U.S. VYJUVEK growth.
• The Nasdaq Composite is up 0.37%, below the threshold for a strong market-wide explanation; monitoring is warranted.